Research Row: Impacting Downstream Capricor Therapeutics (Cap-1002) Edgewise Therapeutics (EDG-5506) FibroGen (Pamrevlumab) Antisense Therapeutics (ATL1102) Cumberland Pharmaceuticals (Ifetroban) 2023 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 11:46 NS Pharma 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 5 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 12:20 Catabasis 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 11:23 Antisense Therapeutics 5 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 13:19 PTC Therapeutics 5 years ago Approved Therapies,Conferences & Meetings 15:43 Sarepta Therapeutics 5 years ago Approved Therapies,Conferences & Meetings «1…2223242526…28»Page 24 of 28